Adilah Bahadoor

Adilah Bahadoor is an accomplished inventor based in Cambridge, MA, who has made significant contributions to the field of pharmaceuticals. With five patents to her name, she stands out for her innovative approaches to complex scientific challenges.

Latest Patents

Among her notable inventions is the patent for the enzymatic transamination of cyclopamine analogs. This invention relates to the preparation of amino-cyclopamines by utilizing the enzymatic transamination of corresponding keto-cyclopamines in the presence of a cofactor and an amino donor. Additionally, she has developed a patent for tetrazolones as inhibitors of fatty acid synthase. This formulation encompasses tetrazolone FASN inhibitors, providing a pharmaceutically acceptable method for treating various disorders, including hyperproliferative disorders, inflammatory disorders, obesity-related conditions, and microbial infections.

Career Highlights

Adilah currently works at Infinity Pharmaceuticals, Inc., a company known for its dedication to innovation in developing novel therapies for critical diseases. Her impressive portfolio of patented inventions showcases her dedication and expertise within the pharmaceutical industry.

Collaborations

Throughout her career, Adilah has collaborated with esteemed colleagues, including Gregg F. Keaney and Alfredo C. Castro. These collaborations not only highlight her ability to work effectively within teams but also reveal her role in advancing scientific research and innovation in her field.

Conclusion

Adilah Bahadoor exemplifies the spirit of innovation with her groundbreaking patents and impactful work at Infinity Pharmaceuticals, Inc. Her contributions continue to pave the way for advancements in pharmaceutical science and illustrate the importance of inventive thinking in addressing critical health challenges.

This text is generated by artificial intelligence and may not be accurate.